(MT Newswires) -- Dutch Philips Group (PHG) CEO Roy Jakobs discusses the consequences of the sleep apnea machine recall. The Dutch medical equipment manufacturer has not given a definitive figure for the cost of the recall, as the legal proceedings are not over, but claims that 99% of defective devices have been replaced. While the company has recorded three consecutive quarters of growth, it points to investments in artificial intelligence, estimated at over a billion euros a year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.23 EUR | +1.00% | -0.67% | +23.75% |
May. 24 | Philips: refinancing for 700 million euros | CF |
May. 24 | Royal Philips Prices EUR700 Million of Notes due 2032 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.75% | 25.42B | |
+7.87% | 223B | |
+11.83% | 195B | |
+18.87% | 144B | |
+30.03% | 111B | |
+2.32% | 65.19B | |
+14.15% | 53.02B | |
+2.68% | 50.28B | |
+6.60% | 44.15B | |
+1.85% | 36.45B |
- Stock Market
- Equities
- PHIA Stock
- News Philips NV
- Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO